Introduction
Sepsis often leads to deterioration of organ function, so-called multiple organ dysfunction syndrome (MODS). Pathophysiologically, impaired control mechanisms of NF-κB activation result in a dysbalance between proinflammatory and anti-inflammatory gene transcription. In regard to hyperinflammation, NF-κB activation is thought to play a central role [1], while being inalienable for the inflammation process [2]. Therefore it is conceivable that both proinflammatory and anti-inflammatory cell functions are mediated by NF-κB in the same cell system. The aim of this study is to elucidate the activation kinetics of NF-κB under long-term stimulation (LTS) and two-time stimulation (TTS), simulating conditions in critical diseases.
Methods
Murine macrophages (cell line RAW 264.7) were cultured in standard medium (DMEM + 10% FCS) and incubated in 0.1 μg/ml, 1.0 μg/ml and 10 μg/ml lipopolysaccharide (LPS). After 5, 10, 20, 30, 60 min, and again after 2, 4, 8, 12, 16, and 24 hours, we analyzed the activity of NF-κB in cellular and nuclear protein extracts using the methods of Electrophoretic Mobility Shift Assay (EMSA) and western blots (p65, IκBα). After 4 hours pre-incubation with 0.1 μg/ml, 1.0 μg/ml and 10 μg/ml LPS, we stimulated again a second time with 1 μg/ml LPS (TTS). The analysis mentioned above was done after 5, 10, 20, 30, 60, and 120 min.
Results
Cells incubated with high concentrations of LPS (10 μg/ml) showed a biphasic activation pattern of NF-κB after 5–10 min and 12–16 hours. Cells incubated with lower LPS concentrations showed no further activation after the early activation peak. After preincubation with 0.1 μg/ml LPS and TTS an unaltered timely activation of NF-κB with delayed IκBα degradation was observed.
Conclusion
The LPS tolerance [3] often described in the literature does not exist in macrophages preincubated with low concentrations of LPS. The biphasic activation pattern of the NF-κB signaling pathway induced by high LPS concentrations occurs possibly within the scope of an anti-inflammatory regulation mechanisms. These results clarify the varying activation kinetic of the NF-κB signaling pathway.
References
- Senftleben U, Karin M. The IKK/NF-kappa B pathway. Crit Care Med. 2002;30:S18–S26. doi: 10.1097/00003246-200201001-00003. [DOI] [PubMed] [Google Scholar]
- Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA. Possible new role for NF-kappaB in the resolution of inflammation. Nat Med. 2001;7:1291–1297. doi: 10.1038/nm1201-1291. [DOI] [PubMed] [Google Scholar]
- Bohuslav J, Kravchenko VV, Parry GC, Erlich JH, Gerondakis S, Mackman N, Ulevitch RJ. Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J Clin Invest. 1998;102:1645–1652. doi: 10.1172/JCI3877. [DOI] [PMC free article] [PubMed] [Google Scholar]